Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN)
CUSIP: 51654W101
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 11,280,432
- Total 13F shares
- 1,346,716
- Share change
- -58,945
- Total reported value
- $19,660,000
- Price per share
- $14.60
- Number of holders
- 19
- Value change
- -$1,578,997
- Number of buys
- 13
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 51654W101?
CUSIP 51654W101 identifies LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 51654W101:
Top shareholders of LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Corriente Advisors, LLC |
13F
|
Company |
6.3%
|
713,806
|
$12,948,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
259,147
|
$4,701,000 | — | 31 Mar 2021 | |
| FLAGSHIP HARBOR ADVISORS, LLC |
13F
|
Company |
1.3%
|
147,671
|
$2,679,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.45%
|
50,702
|
$920,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
45,830
|
$831,000 | — | 31 Mar 2021 | |
| Redmond Asset Management, LLC |
13F
|
Company |
0.4%
|
44,991
|
$816,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.37%
|
42,106
|
$764,000 | — | 31 Mar 2021 | |
| WOLFF WIESE MAGANA LLC |
13F
|
Company |
0.24%
|
27,075
|
$491,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.21%
|
23,650
|
$429,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
12,629
|
$229,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
11,775
|
$213,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.1%
|
11,192
|
$203,000 | — | 31 Mar 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
3,643
|
$66,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
2,166
|
$39,000 | — | 31 Mar 2021 | |
| US BANCORP \DE\ |
13F
|
Company |
0.02%
|
2,000
|
$36,000 | — | 31 Mar 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
1,300
|
$24,000 | — | 31 Mar 2021 | |
| Spire Wealth Management |
13F
|
Company |
0.01%
|
1,050
|
$19,000 | — | 31 Mar 2021 | |
| Bank Julius Baer & Co. Ltd, Zurich |
13F
|
Company |
0.01%
|
1,000
|
$18,000 | — | 31 Mar 2021 | |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
900
|
$17,000 | — | 31 Mar 2021 | |
| Mesirow Financial Investment Management, Inc. |
13F
|
Company |
0.01%
|
818
|
$15,000 | — | 31 Mar 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
62
|
$1,000 | — | 31 Mar 2021 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
43
|
$1,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
40
|
$1,000 | — | 31 Mar 2021 |
Institutional Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q2 2021
As of 30 Jun 2021,
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,346,716 shares.
The largest 10 holders included
Corriente Advisors, LLC, VANGUARD GROUP INC, GWM Advisors LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Redmond Asset Management, LLC, WOLFF WIESE MAGANA LLC, Bank of New York Mellon Corp, BlackRock Inc., and NORTHERN TRUST CORP.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
21
Q2 2021 holders
19
Holder diff
-2
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.